experience of "training"
Release time:
2020-07-22
"Training" Experience
Some time ago, I participated in a trial production of the product. This was a rare exercise opportunity for me and I learned a lot. Through this "training", I realized that in production management, we should not only master the pharmaceutical technology, but also be familiar with and master the equipment in order to use the equipment skillfully.
In this "training", I felt that I was not fully prepared. Let's take a small matter. In the production process, because I did not fully communicate with the engineers of the other party in advance, I directly chose domestic activated carbon when preparing materials during the day. As a result, when I used it in the middle of the night, the engineers said that I would use imported activated carbon. I had to contact the relevant person in charge temporarily to receive imported activated carbon. If you can not get imported activated carbon at that time, it will not only affect the production schedule, but also may bring risks to the quality of drugs. If I am responsible for product production in the future, I will definitely make a detailed production schedule, personnel schedule, material list (name, model, dosage, manufacturer and use time, etc.), equipment list (name, model and other special requirements), work coordination contact list (including which department needs help and which work to cooperate, when do you need their help, etc.)...
During the trial production of the product, the workshop technicians must follow up the whole process. Workshop technicians take turns to track, I personally think it is not very feasible, because our technical strength is relatively weak, and the harvest of visiting the site is far more than that obtained by watching other people's summaries, records and explanations, and the results are also first-hand information, and we can also communicate with engineers at any time and understand more deeply. There is a saying that seeing is better than hearing. I think it is quite appropriate to use it here. As for the limited energy of a person to track the whole process, I personally think that even if the trial production is tracked throughout the whole process, it will only take a few days, and no matter how hard and tired it is, we must get used to continuous fighting and hard fighting. Moreover, the engineer who handed over the process is also a person. He can do it well. I believe we can do it and do it better.
site is a teaching place, but also a practice place. The trial production process is the time when the whole product has the most problems. The site can not only find many problems, but also solve them quickly. In the process of drug production, we should always follow the principle of on-site problem solving, because the scene is the place where problems can be found and the inspiration for solving problems can be triggered most. (Liu Bin)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page